American Gene Technologies International

About:

AGT is pioneering gene therapy solutions to achieve permanent cures for human diseases, including a possible cure for HIV in clinical trials

Website: http://americangene.com

Twitter/X: americangene

Top Investors: Alumni Ventures, Gaingels, National Institutes of Health, Vye Ventures, 10X Capital

Description:

American Gene Technologies (AGT) is focused on creating long-term value for patients, society, investors and donors by developing and testing cutting-edge gene therapies to cure some of humanity’s worst diseases. AGT’s HIV cure clinical trial could not only lead to a blockbuster drug that brings relief to one of society's most elusive epidemics, but it could prove the efficiency and effectiveness of AGT’s platform technologies to cure dozens of diseases ranging from viruses to cancers.

Total Funding Amount:

$23.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Rockville, Maryland, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)americangene.com

Founders:

Jeffrey A. Galvin

Number of Employees:

11-50

Last Funding Date:

2022-04-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai